ArticleCancer medicine2014

Contribution of transcription factor, SP1, to the promotion of HB-EGF expression in defense mechanism against the treatment of irinotecan in ovarian clear cell carcinoma.

Kohei Miyata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.